Previous research has suggested that controlling blood pressure may help lower the risk of developing Alzheimer’s disease. Now, in the search for effective therapies for the memory-stealing disease, scientists have shown evidence in the lab that an approved drug for high blood pressure may be able to reduce cell damage often linked to Alzheimer’s.
The findings, published online Jan. 28 in the journal Alzheimer’s Research and Therapy, support the potential use of the drug candesartan – as well as other Angiotensin receptor blockers (ARBs) – for the early treatment of Alzheimer’s disease.
